Watch our exclusive interview with the CEOs of MJ MedTech, a subsidiary of Wuhan General (OTC: WUHN), and Biodelta, as they discuss the company's near-term rollout in South Africa and plans to expand into neighboring countries. An early entrant in a multi-billion-dollar market opportunity, WUHN is ideally positioned for upside. Visit WUHNinfo.com to learn more.
0 Comments